|
NIBSC 19/166 Insulin-like Growth Factor I, for Immunoassay
- 英文名称：Insulin-like Growth Factor I, for Immunoassay
- 品牌：NIBSC
- 产地：国外
- 型号：详询
- 货号：19/166
- 发布日期： 2022-08-29
- 更新日期： 2024-08-12
产品详请
| 产地 | 国外 |
| 品牌 | NIBSC |
| 货号 | 19/166 |
| 用途 | 详询 |
| 英文名称 | Insulin-like Growth Factor I, for Immunoassay |
| 包装规格 | 详询 |
| 纯度 | 详询% |
| CAS编号 | |
| 别名 | Insulin-like Growth Factor I, for Immunoassay |
| 分子式 | 详询 |
| 是否进口 |
Product description：Insulin-like Growth Factor I, for Immunoassay (2nd WHO international Standard)
Product number：19/166
Category：Diagnostics/Protein Hormones and Endocrine Products
Keywords：IGF-I, growth, endocrine, immunoassay
Type of standard：International Standard
The WHO International Standard for Insulin-like Growth Factor-I (IGF-I), recombinant, human, is the primary reference material for the calibration of IGF-I immunoassays. This preparation, coded 19/166, containing recombinant human IGF-I, was ampouled and evaluated for its suitability to serve as a WHO International Standard by international collaborative study. It was established as the 2nd International Standard for Insulin-like growth factor-I, recombinant, human, by the Expert Committee for Biological Standardization of the World Health Organization in October 2020. It replaces the 1st International Standard, for Insulin-like growth factor-I (IGF-I), recombinant, human, coded 02/254.
Product number：19/166
Category：Diagnostics/Protein Hormones and Endocrine Products
Keywords：IGF-I, growth, endocrine, immunoassay
Type of standard：International Standard
The WHO International Standard for Insulin-like Growth Factor-I (IGF-I), recombinant, human, is the primary reference material for the calibration of IGF-I immunoassays. This preparation, coded 19/166, containing recombinant human IGF-I, was ampouled and evaluated for its suitability to serve as a WHO International Standard by international collaborative study. It was established as the 2nd International Standard for Insulin-like growth factor-I, recombinant, human, by the Expert Committee for Biological Standardization of the World Health Organization in October 2020. It replaces the 1st International Standard, for Insulin-like growth factor-I (IGF-I), recombinant, human, coded 02/254.
